The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 05, 2025

Filed:

Jul. 29, 2024
Applicant:

Genequantum Healthcare (Suzhou) Co., Ltd., Suzhou, CN;

Inventors:

Cao Lv, Suzhou, CN;

Jinduo Yuan, Suzhou, CN;

Gang Qin, Suzhou, CN;

Meijun Xiong, Suzhou, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/54 (2017.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/68 (2017.01); C12N 9/24 (2006.01);
U.S. Cl.
CPC ...
A61K 47/549 (2017.08); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/545 (2017.08); A61K 47/68 (2017.08); C12N 9/2402 (2013.01); C07K 2317/41 (2013.01); C07K 2317/52 (2013.01);
Abstract

A method for preparing an antibody-drug conjugate. The antibody-drug conjugate is formed by means of site-directed conjugation on the basis of an N-glycosylation site of an Fc region of an antibody. The method comprises: (1) providing a donor containing an oxazoline oligosaccharide, an antibody containing a GlcNAc motif, and an immobilized endoglycosidase having a glycoside transfer activity; and (2) covalently linking the activated donor containing the oxazoline oligosaccharide to the antibody containing the GlcNAc motif by means of the catalytic action of the endoglycosidase; therefore, one-step conjugation is realized. The present invention also relates to an endoglycosidase fusion protein, which comprises a covalently linked endoglycosidase, a Halo tag, and/or a His tag. The present invention also relates to an immobilized endoglycosidase fusion protein obtained by means of immobilizing an endoglycosidase fusion protein on a support, a prepacked column filled with the immobilized fusion protein, and a method for purifying an antibody conjugate by using the immobilized endoglycosidase fusion protein.


Find Patent Forward Citations

Lv, Cao. (2025). Immobilized endoglycosidase fusion protein and use thereof (U.S. Patent No. 12377151). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12377151

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…